BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
Angiogenesis
,
Ischemia
,
Intestine
,
Pharmacogenetics
,
Ciprofibrate
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
influenza a virus, h5n1 subtype
Summary
General Info
Curated Studies
Most Correlated Studies
Tracheobronchial epithelial cells infected with H3N2, attenuated H5N1, and H1N1 viruses
Primary monocytes infected with high or low pathogenicity influenza viruses
Lungs infected with various H. influenzae strains - Timecourse
Early and sustained innate immune response to highly pathogenic influenza virus
Macrophages infected with H1N1 and H5N1 strains of Influenza A
Explore Curated Studies Results
Literature
Most Relevant Literature
HA N193D substitution in the HPAI H5N1 virus alters receptor binding affinity and enhances virulence…
Evolution and biological characterization of H5N1 influenza viruses bearing the clade 2.3.2.1 hemagg…
A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1…
Neurotropic Highly Pathogenic Avian Influenza A(H5N1) Virus in Red Foxes, Northern Germany.
Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (…
A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivat…
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents …
Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ